Passez à l'illimité avec Magzter GOLD
Obtenez un accès illimité à plus de 9 000 magazines, journaux et articles Premium pour seulement
Essayer OR - Gratuit
Does US cancer drug nod make Cipla attractive?
Mint New Delhi
|April 18, 2025
Cipla, which makes HIV, respiratory and cancer drugs, is targeting North America with generic launches
Cipla Ltd's shares have surged 6% since last week when it announced the final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb's Abraxane, a cancer drug. Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump's tariffs loom?
"One product approval by itself doesn't suddenly make a company more attractive," said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. "Earlier-than-expected approval for Abraxane is positive, but tariffs will have a bearing on Cipla."
Cette histoire est tirée de l'édition April 18, 2025 de Mint New Delhi.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint New Delhi
Mint New Delhi
EV, hydro boom to power 6x rise in battery storage by ‘47
India is preparing to meet a projected cumulative battery energy storage capacity of nearly 3 terawatt-hours (TWh) by 2047 across electric mobility, power, and electronic components, according to two people aware of the development, with electric vehicles (EVs) expected to contribute a third of the demand.
2 mins
November 27, 2025
Mint New Delhi
Taxpayer base soars, but return filings lag sharply: CBDT data
India’s income tax base is growing faster than the number of those conscientiously filing returns, driven by the expanding reach of the tax deducted at source (TDS) system, according to latest data from the central board of direct taxes (CBDT).
3 mins
November 27, 2025
Mint New Delhi
INSIDE THE QUIET RISE OF A GURUGRAM DEVELOPER
Rising from the ashes of NCR's property crisis, Signature Global became India’s 5th-largest listed realty firm in FY25 by sales
7 mins
November 27, 2025
Mint New Delhi
Market nears peak on dollar tailwind
Stocks jump 1.2%, but futures rollovers signal weak conviction
3 mins
November 27, 2025
Mint New Delhi
SP Eyes Tata exit to cut debt costs
Debt-laden Shapoorji Pallonji Group is banking on Tata Trusts softening the stance on its potential exit from Tata Sons to reduce its borrowing costs, two people aware of the matter said.
2 mins
November 27, 2025
Mint New Delhi
Why computers are selling like hot cakes again
Sales of laptops, desktops and tablets had a bad time in India after a pandemic boom.
2 mins
November 27, 2025
Mint New Delhi
Candidates using AI? No, thanks, say IIT recruiters
As the annual placement season dawns at the Indian Institutes of Technology (IITs), colleges and recruiters are working to bar artificial intelligence (AI) tools and prevent cheating at test venues, a concern that first rose last year.
3 mins
November 27, 2025
Mint New Delhi
Reliance JV, L&T to plough $13.5 bn into data centres
India’s data-infrastructure buildout hit a $13.5-billion inflection point on Wednesday, with a Reliance Industries Ltd (RIL) joint venture and Larsen & Toubro (L&T) announcing large-scale investments in data centres, driven by surging demand for artificial intelligence (AI) applications.
2 mins
November 27, 2025
Mint New Delhi
Softbank’s 40% fall from peak shows worry on OpenAI bet
Growing unease over frothy artificial intelligence (AI) valuations is weighing on shares of SoftBank Group Corp.
2 mins
November 27, 2025
Mint New Delhi
PepsiCo taps gourmet taste buds with Red Rock Deli’s India debut
Snack and cola maker PepsiCo is finally giving gourmet a chance with the launch of Red Rock Deli chips, priced ₹60 and ₹125 a pack, in a shift from its years-long focus on mass-market Lay's that starts as low as ₹5.
2 mins
November 27, 2025
Listen
Translate
Change font size